Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
https://finance.yahoo.com/news/pds-biotechnology-expands-versatile-002-125300514.html
$PDSB
Bust through 1.75, and you're probably gonna start blowing short stops.
Keep in mind, those short stops become market buy orders when they get hit, so don't be surprised if the price takes a pretty sizable jump...
$HEPA
Scared money don't make money Swiss cheese me please another soon to be 7 figure winner for me how about them apples
My options are killing it! 10x
$30.00 PLUS Soon watch and learn from the best$!
KaBOOMAGE
Planet of the Apes
https://gfycat.com/favorablefittingamphibian-gorilla-walking
$BB
Chen the CEO wants that big bonus Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
$BB
Accumulating more meticulously!
$MNMD
Should be getting confirmation from Brazil soon!
$PDSB
100.00+ price target AMC the peoples stock! CEO gets it."I work for the shareholders" Adam Aron AMC CEO
$AMC
CRV431 in NASH Phase 2a Preliminary Conclusions
Reduction in transaminases at 28 days signals early efficacy in F2/F3 NASH subjects.
CRV431 concentration predicts reductions in serum alanine transaminase.
Trial Simulations suggest greater expected efficacy at 150 mg and 225 mg dose levels.
Bioinformatics with AI-POWR reveal significant interactions with collagen regulating genes.
Confirmation of these effects will be fully evaluated using the 225 mg cohort and the final genomic,
lipidomic, and biomarker data for a full simulation of the Phase 2b Trial.
Lots of potential new multi millionaires will be made in HEPA like there where in PDSB over the last year
Chart Events
Bullishpattern detected
$HEPA
CRV431 in NASH Phase 2a Preliminary Conclusions
Reduction in transaminases at 28 days signals early efficacy in F2/F3 NASH subjects.
CRV431 concentration predicts reductions in serum alanine transaminase.
Trial Simulations suggest greater expected efficacy at 150 mg and 225 mg dose levels.
Bioinformatics with AI-POWR? reveal significant interactions with collagen regulating genes.
Confirmation of these effects will be fully evaluated using the 225 mg cohort and the final genomic,
lipidomic, and biomarker data for a full simulation of the Phase 2b Trial.
No approved drugs for Nash 14 Billion market over the next few years.
$HEPA
Making 6 figures in my sleep LOL what a beast!
$BB
PDSB since the last time I posted about a month ago up 200% going higher another one that will skyrocket soon is HEPA. Your welcome!
HEPA Phase 2B no Nash drugs approved to date. 130 million market cap 120 million in cash burns 19 million a year. Great team CEO Foster brought a blockbuster drug to market via FDA in his last company.
https://12ewye24eigk3g5kwa2dxjzm-wpengine.netdna-ssl.com/wp-content/uploads/2021/04/4thGlobal_NASH_Congress_Draft_20Apr2021_FINAL-1.pdf
https://hepionpharma.com/ai-powr/
https://hepionpharma.com
HEPA Tackling Chronic Liver Disease - CRV431 Mechanism of Action.
4th Global Nash conference HEPA Presentation.
https://12ewye24eigk3g5kwa2dxjzm-wpengine.netdna-ssl.com/wp-content/uploads/2021/04/4thGlobal_NASH_Congress_Draft_20Apr2021_FINAL-1.pdf
HEPA Lots of potential look for fast tracking on NASH.
Phase 2B Nash trial starts Q3 this year.
No approved drugs for NASH HEPA CRV431 is very safe and efficacy looks very promising.
CEO Foster has brought a blockbuster drug to market in his last company.
For newcomers, Hepion is already moving on to Phase IIb with CRV431 in NASH, based on the low-dose (75mg) results alone, which after 28 days were as good as what Madrigal's P3 lead NASH drug took 12 weeks to achieve.
Having noted that, the higher CRV431 dose (225mg) results are expected to be even far better, with AI-POWR projections shown in slides from this recent presentation Pat Mayo gave at the Global NASH Congress. Take a look at pages 22-25
https://12ewye24eigk3g5kwa2dxjzm-wpengine.netdna-ssl.com/wp-content/uploads/2021/04/4thGlobal_NASH_Congress_Draft_20Apr2021_FINAL-1.pdf
Also, keep in mind tha HEPAt CRV431 is far and away the best anti-fibrotic in the clinic today. Nothing else compares!
HEPA Another molecule is coming to the pipeline, P2 studies are being planned with CRV431 in multiple myeloma, hepatoma, probably IPF, some anti-viral applications, and so forth, all with enormous potential, based on AI-POWR projections Here's much of what we know about the AI-POWR platform. Development of the platform began in what's called the "AI winter", in the early 1990's, long before others were even thinking about employing AI in drug development. Hepion recently put it into full operation, after nearly thirty years of development, so they are way ahead in this area. The potential cost savings for clinical trials is incalculable!.
https://hepionpharma.com/ai-powr/
MDGL 1.8 Billion market cap Phase 3 results so far look mediocre at best 300 million in cash.
HEPA 130 million market cap Phase 2B commencing soon. 120 million in cash.
$HEPA
what a monster stock!!
$BB
Thanks!
PDSB May 2021 Biz Presentation.
https://www.pdsbiotech.com/images/pdf/presentation/2021/may/PDSB_Corporate_Overview_-_May_24_2021_v5.pdf
PDSB website.
https://www.pdsbiotech.com/
52 week low 1.12
52 week high 12.46
Kaboomage
$PDSB
Thanks PDSB is a beast one the best performing biotech microcaps in the last 12 months. The sky is the limit here! I promised my girlfriend I would spend less time working. To all the longs at PDSB congrats greener pastures awaits us.
$PDSB
Thank you Maui was great first getaway in over a year and finally bought my dream house in Maui.
PDS Biotech to Host Oncology R&D Day on June 16, 2021
https://www.globenewswire.com/news-release/2021/06/01/2239492/0/en/PDS-Biotech-to-Host-Oncology-R-D-Day-on-June-16-2021.html
$PDSB
My next moonshot pick.
Recent Picks that netted me millions
20x NVAX
9x PDSB
HEPA is my next pick.
HEPA 120 Million in cash.
HEPA 130 Million market cap.
HEPA 13 employees burned 19 million last year.
Non-Alcoholic Steatohepatitis (NASH) Market To Reach USD 13.38 Billion By 2026
Institutions own majority of the shares after the last offering at $2.00
The company said it has conducted nine individual animal studies of fibrosis and found consistent and statistically significant antifibrotic effects of CRV431 in every one of these studies. Antifibrotic activity has also been observed in previously reported studies conducted by an independent U.K. laboratory that studied explanted liver and lung tissues taken from human donors. Taken together, these animal and human tissue experiments give the company a "great deal of confidence" that CRV431 has beneficial antifibrotic effects that are expected to be borne out clinically.
Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Office.r
https://www.biospace.com/article/releases/former-novo-nordisk-executive-dr-todd-m-hobbs-joins-hepion-pharmaceuticals-as-chief-medical-officer/
Showing better results than MDGL at 28 days then MDGL 2 Billion market cap.
HEPA Tackling Chronic Liver Disease - CRV431 Mechanism of Action.
Just got back from Maui with some of my PDSB & NVAX gains bought a second home ocean view 2.2 Million put a million down and I'm still holding 100k PDSB shares free and clear. Also found a new gem just started a position in HEPA & went long BB at 9.19 last week. Love the $20.00 upgrade today HCW
$PDSB
Will reload if it hits $4.00
I had a bad feeling about the patent protection with these vaccines.
Tomorrow is.a new day!
$PDSB
If you sold your shares call the police you have been robbed. Mind Bending Short Squeeze on tap.
HGEN Lenz is an agnostic treatment that works against CV-19 Variants.
HEALTH AND SCIENCE
CDC projects a surge in U.S. Covid cases through May due to variants before vaccinations drive a ‘sharp decline’
https://www.cnbc.com/2021/05/05/cdc-projects-a-surge-in-us-covid-cases-through-may-due-to-bpoint1point1point7-variant-before-a-sharp-decline-.html
Humanigen’s portfolio is broad and currently, we are open to strategic partnership discussions in the areas of:
Lenzilumab™ COVID-19 prevention / treatment of Hyper-inflammation / Cytokine Storm
Phase 3 & Launch.
Lenzilumab CAR-T increased efficacy and safety
Phase 1/2.
Lenzilumab Eosinophilic Asthma
Phase 3.
Ifabotuzumab Solid tumors
Phase 2.
EMR1 Eosinophilic diseases
Phase 1/2.
Early stage opportunities for innovative programs with our proprietary CARs.
HGEN Pipeline:
https://www.humanigen.com/pipeline
HGEN 175 Million in cash.
HGEN 43% Shares Floating are short.
Lenz billion dollar plus blockbuster drug.
Diamond Hands:
https://giphy.com/gifs/justin-doge-dogecoin-mz7iww9tCUnJJeZvGN
$HGEN
43% floating shares short this is a recipe for a parabolic game stop type short squeeze. A biotech company that has all the boxes checked off for a legendary run.
1. Blockbuster billion dollar plus drug.
2. Strong cash postilion 175 million
3. Grade A management team.
4. Nearing 60% of the shares owned by institutions and insiders.
5. One of the largest percentage shorted stocks on the Nasdaq 43% of the floating shares SHORTED!!
6. Diverse pipeline with world renown partners.
7. Multiple catalyst to come.
8. Buy out target.
$HGEN
$GME
I told you the shorts where going to get REKT they will take this well into the 30’s soon along with the half of dozen other catalysts the companies got multiple Jack hammers it’s about to drop. I’m coming for that ass shortie.
43% of the float is short at HGEN.
$HGEN
Just getting started it’s the early innings of a double header.
My spider senses tell me a new all time high is coming and possibly $100.00 plus this Management team at HGEN is the best of the best.
43% of the HGEN float is shorted this adds another angle for a massive run.
Bid it up longs make these roaches pay!
$HGEN
Here we go Lets do this Longs new Millionaires will be made here.
43% of the floating shares SHORTED this can go parabolic.
$HGEN
$GME
Longs lets power up and get this over the 19.26 Resistance. Once we break it its off to the races. The time is now.
$HGEN
HGEN Short Squeeze!!! Release the Kraken Bid it up this is crucial for the Death Blow.
https://giphy.com/gifs/IntoAction-thumbs-up-epsteinj-short-squeeze-O1QY4jjt2M9TErx4QW
$HGEN
Billion dollars in Revenue with a company who market cap is a billion This stock is going to launch into orbit soon with the Fact some short clowns have 43% of the float shorted man are they stupid.
$40.00-$50.00 is coming and if they exceed their 100k treatments its going to a $100.00 Plus.
$HGEN
19.26 Let's do this and Gamma Squeeze these short Leeches.
$HGEN
Lets send these shorts to their resting place Scum of the earth. 43% floating shares short.
Resistance Levels People man up and slap that ask with authority.
18.51
88.71
19.26
New Highs will come sooner than later Book it!
$HGEN
Shorts are Toast stick in a fork in it they know there about to get decimated. These clowns just showed their hand.
Make them shorts pay for their stupidly Accumulate! & bid it up.
$HGEN
It can happen in a blink of an eye. Know what you own.
Wide array of catalysts one of the largest shorted shares on the market with a Billion dollar plus drug coming to market & from what I hear multiple companies interested in Buying HGEN
$HGEN
World’s Most Vaccinated Nation Activates Curbs as Cases Rise
https://www.bloombergquint.com/politics/world-s-most-vaccinated-nation-reintroduces-curbs-as-cases-surge
It's the perfect storm for HGEN
Covid mutant variants in rampant outbreaks like India & Brazil mean ‘no one is safe’ as pandemic could last until 2024
https://www.thesun.co.uk/news/14779684/covid-mutant-india-brazil-pandemic-2024/
43% of the floating shares of HGEN are short. This is going to be fun!
JPM: Deal-making still a 'top priority' at Bristol Myers as CEO eyes midsize buys
https://www.fiercepharma.com/pharma/jpm-21-m-a-still-a-top-priority-at-bristol-myers-as-ceo-eyes-midsize-deals
$HGEN
$GME
Mother of all short squeezes can happen at any time. 43% of the floating shares are short! Lets Gamestop these shorts & launch the share price into outer space.
So many catalysts & Hammers the company can drop. Including Buyout. Hint Hint:JPM: Deal-making still a 'top priority' at Bristol Myers as CEO eyes midsize buys
1.Lenzilumab™ COVID-19 prevention / treatment of Hyper-inflammation / Cytokine Storm
Phase 3 & Launch.
2.Lenzilumab CAR-T increased efficacy and safety
Phase 1/2.
3.Lenzilumab Eosinophilic Asthma
Phase 3.
4.Ifabotuzumab Solid tumors
Phase 2.
5.EMR1 Eosinophilic diseases
Phase 1/2.
6.Early stage opportunities for innovative programs with our proprietary CARs.
$HGEN
ENDLESS RISE Covid mutant Variants in rampant outbreaks like India & Brazil mean ‘no one is safe’ as pandemic could last until 2024
https://www.the-sun.com/news/2819814/covid-mutant-india-brazil-pandemic-2024/
COVID is killing 120 people an hour in India, and it could stay "really grim" for years.
https://www.cbsnews.com/news/india-covid-crisis-deaths-vaccine-oxygen/
HGEN will have a Billions in revenue potential for many years with LENZ.
43% Shares floating short.
175 Million in cash.
Intuitions & Insiders own 55% of the shares very small float.
HGEN Twitter:
https://twitter.com/humanigen
HGEN Website:
https://www.humanigen.com
Diamond Hands.
https://giphy.com/gifs/justin-doge-dogecoin-mz7iww9tCUnJJeZvGN
$HGEN
Time to Party We need Anvisa to give us the green light. Such a fluid situation with this crazy in government in Brazil they have turned down a few vaccines lets hope its different for PDSB. I really don't want to test $4.00 again if nothing pans out after all this.
$PDSB
Things are gonna get explosive soon.
Like I said, the Bollinger Bands are getting extra tight now, the daily short volume transitions are monstrous, seller exhaustion., And it's nearing the time that it just f'n blows up!
Humanigen’s portfolio is broad and currently, we are open to strategic partnership discussions in the areas of:??
Lenzilumab™ COVID-19 prevention / treatment of Hyper-inflammation / Cytokine Storm
Phase 3 & Launch.
Lenzilumab CAR-T increased efficacy and safety
Phase 1/2.
Lenzilumab Eosinophilic Asthma
Phase 3.
Ifabotuzumab Solid tumors
Phase 2.
EMR1 Eosinophilic diseases
Phase 1/2.
Early stage opportunities for innovative programs with our proprietary CARs.
HGEN Pipeline:
https://www.humanigen.com/pipeline
HGEN 175 Million in cash.
HGEN 43% Shares Floating are short.
Diamond Hands:
https://giphy.com/gifs/justin-doge-dogecoin-mz7iww9tCUnJJeZvGN
$HGEN
Solid Post!
HGEN 43% of the shares floating are short.
https://giphy.com/gifs/IntoAction-thumbs-up-epsteinj-short-squeeze-O1QY4jjt2M9TErx4QW
$HGEN
Hopefully we get positive news this week.
$PDSB
Bollinger Bands are really contracting now.
Squeeeeeezing......
HGEN 43% floating shares Shorted
Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients.
CNN Poll: About a quarter of adults say they won't try to get a Covid-19 vaccine.
https://www.cnn.com/2021/04/29/politics/cnn-poll-covid-vaccines/index.html?et_rid=1745420317&s_campaign=fastforward:newsletter
Vaccination rate sinks to lowest point in almost 2 months as COVID-19 kills 32 more Illinoisans
About 60% of Illinois adults have gotten at least one shot, but demand for the vaccine has dipped by 34% over the past three weeks.
https://chicago.suntimes.com/coronavirus/2021/5/1/22414050/illinois-coronavirus-vaccine-cases-deaths-pritzker-positivity-reopen-covid-19-may-1
$HGEN
Short Squeeze 43% of the HGEN float is short one of the largest shorted stocks on the market.
https://giphy.com/gifs/IntoAction-thumbs-up-epsteinj-short-squeeze-O1QY4jjt2M9TErx4QW
$HGEN
$GME